380 related articles for article (PubMed ID: 27646952)
1. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
[TBL] [Abstract][Full Text] [Related]
2. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
[TBL] [Abstract][Full Text] [Related]
3. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
[TBL] [Abstract][Full Text] [Related]
4. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
[TBL] [Abstract][Full Text] [Related]
5. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.
Liu TC; Hamilton N; Hawkins W; Gao F; Cao D
Am J Surg Pathol; 2013 Jun; 37(6):853-9. PubMed ID: 23598967
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
[TBL] [Abstract][Full Text] [Related]
7. The latest exploration of staging and prognostic classification for pancreatic neuroendocrine tumors: a large population-based study.
Gao S; Pu N; Liu L; Li C; Xu X; Wang X; Lou W
J Cancer; 2018; 9(9):1698-1706. PubMed ID: 29760809
[No Abstract] [Full Text] [Related]
8. Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms.
Zhang Y; Shang L; Zhang PP; Chen LH; Wang W; Fang C; Qiu M; Feng XY; Zhou L; Zhang M; Tan HY; Qiu XD; Wang H; Lin R; Zhang Q; Zeng YJ; Jin KZ; Yu XJ; Shen L; Chen MH; Li J; Li LP; Chen J
Cancer Med; 2019 Sep; 8(11):5000-5011. PubMed ID: 31293053
[TBL] [Abstract][Full Text] [Related]
9. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors.
Strosberg JR; Cheema A; Weber J; Han G; Coppola D; Kvols LK
J Clin Oncol; 2011 Aug; 29(22):3044-9. PubMed ID: 21709192
[TBL] [Abstract][Full Text] [Related]
10. Revised nodal stage for pancreatic neuroendocrine tumors.
Luo G; Jin K; Cheng H; Guo M; Lu Y; Wang Z; Yang C; Xu J; Gao H; Zhang S; Zhang B; Long J; Xu J; Ni Q; Liu C; Yu X
Pancreatology; 2017; 17(4):599-604. PubMed ID: 28610828
[TBL] [Abstract][Full Text] [Related]
11. Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
Lu J; Zhao YJ; Zhou Y; He Q; Tian Y; Hao H; Qiu X; Jiang L; Zhao G; Huang CM;
Br J Surg; 2020 Feb; 107(3):248-257. PubMed ID: 31971627
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
Abdel-Rahman O
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
[TBL] [Abstract][Full Text] [Related]
13. Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database.
You Y; Jang JY; Kim SC; Yoon YS; Park JS; Cho CK; Park SJ; Yang JD; Lee WJ; Hong TH; Ahn KS; Jeong CY; Lee HK; Lee SE; Roh YH; Kim HJ; Kim H; Han IW
Cancer Res Treat; 2019 Oct; 51(4):1639-1652. PubMed ID: 30999719
[TBL] [Abstract][Full Text] [Related]
14. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
Martin JA; Warner RR; Wisnivesky JP; Kim MK
Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622
[TBL] [Abstract][Full Text] [Related]
15. Which Staging System Is More Suitable for Gastric Neuroendocrine Cancer and Mixed Adenoneuroendocrine Carcinomas? A Multicenter Cohort Study.
Lin J; Zhao Y; Zhou Y; Hao H; He Q; Tian Y; Zou B; Zhao G; Qiu X; Jiang L; Li Z; Xu Y; Xue F; Fu W; Xu Z; Li Y; Li S; Chen J; Zhou X; Zhu Z; Li H; Li Y; Li E; Cai L; Jia G; Xie JW; Li P; Zheng CH; Huang CM
Neuroendocrinology; 2021; 111(11):1130-1140. PubMed ID: 31940636
[TBL] [Abstract][Full Text] [Related]
16. Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors.
Wang H; Ding D; Qin T; Zhang H; Liu J; Zhao J; Wu CH; Javed A; Wolfgang C; Guo S; Chen Q; Zhao W; Shi W; Zhu F; Guo X; Li X; Peng F; He R; Xu S; Jin J; Wu Y; Nuer A; Edil B; Tien YW; Jin G; Zheng L; He J; Liu J; Liu Y; Wang M; Qin R;
HPB (Oxford); 2022 May; 24(5):681-690. PubMed ID: 34836754
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors.
Kim BS; Park YS; Yook JH; Kim BS
Medicine (Baltimore); 2016 Jul; 95(30):e3977. PubMed ID: 27472674
[TBL] [Abstract][Full Text] [Related]
18. TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution.
Yang M; Zeng L; Zhang Y; Wang WG; Wang L; Ke NW; Liu XB; Tian BL
Medicine (Baltimore); 2015 Mar; 94(12):e660. PubMed ID: 25816036
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
Li X; Gou S; Liu Z; Ye Z; Wang C
Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
[TBL] [Abstract][Full Text] [Related]
20. [Interpretation and evaluation of the American Joint committee on Cancer (AJCC) 8th Edition Staging System for patients with gastroenteropancreatic neuroendocrine tumors].
Chen L; Zhou Z; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):972-976. PubMed ID: 28900985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
